U.S. drugmakers Johnson & Johnson JNJ.N and Eli Lilly LLY.N increased spending on security for their top executives in 2024, citing increased threats after a UnitedHealth insurance executive was murdered outside the company’s investor meeting in December, regulatory filings showed. …